Predictions
Phio Pharmaceuticals Corp.
Start price
Target price
Perf. (%)
€21.38
11.04.22
11.04.22
-
11.04.23
11.04.23
-36.57%
17.04.22
17.04.22
Commerce Resources Corp.
Start price
Target price
Perf. (%)
€0.24
11.04.22
11.04.22
-
11.04.23
11.04.23
-45.19%
18.05.22
18.05.22
MedAvail Holdings Inc.
Start price
Target price
Perf. (%)
€1.98
11.04.22
11.04.22
€0.000
11.04.23
11.04.23
39.39%
18.04.22
18.04.22
Could be worthwhile Investment >10% per year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
MedAvail Holdings Inc.
Start price
Target price
Perf. (%)
€1.98
11.04.22
11.04.22
€0.000
11.04.23
11.04.23
-5.05%
02.05.22
02.05.22
Could be very worthwhile Investment >20% year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Decining EBIT margin than peer group
Affimed N.V.
Start price
Target price
Perf. (%)
€4.75
11.04.22
11.04.22
-
11.04.23
11.04.23
-41.07%
08.06.22
08.06.22
Could be worthwhile Investment >10% per year
Genocea Biosciences Inc.
Start price
Target price
Perf. (%)
€0.55
11.04.22
11.04.22
-
11.04.23
11.04.23
-93.64%
12.04.23
12.04.23
Advanced Merger Partners Inc.
Start price
Target price
Perf. (%)
€9.18
11.04.22
11.04.22
-
11.04.23
11.04.23
-1.67%
12.04.23
12.04.23
BBI Bürgerliches Brauhaus Immobilien AG
Start price
Target price
Perf. (%)
€27.40
11.04.22
11.04.22
-
11.04.23
11.04.23
-43.80%
12.04.23
12.04.23
Phio Pharmaceuticals Corp.
Start price
Target price
Perf. (%)
€23.99
11.04.22
11.04.22
-
11.04.23
11.04.23
-42.66%
19.04.22
19.04.22
MGI Digital Graphic Technology
Start price
Target price
Perf. (%)
€37.00
11.04.22
11.04.22
€39.00
11.04.23
11.04.23
-30.81%
12.04.23
12.04.23
Epam Systems Inc.
Start price
Target price
Perf. (%)
€284.95
10.04.22
10.04.22
€300.00
10.04.23
10.04.23
14.30%
22.07.22
22.07.22
High Investments for future growth
Very valuable balance sheet
Leading role in innovation
Very positive Cash Flow expected
Pfeiffer Vacuum
Start price
Target price
Perf. (%)
€172.20
10.04.22
10.04.22
€200.00
10.04.23
10.04.23
1.28%
26.11.22
26.11.22
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Fair valuation
Good rating
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€114.00
10.04.22
10.04.22
-
10.04.23
10.04.23
-32.91%
11.04.23
11.04.23